What is the current stock price of Design Therapeutics, Inc.?

As of the latest update, Design Therapeutics, Inc.'s stock is trading at $10.78 per share.

What's happening with Design Therapeutics, Inc. stock today?

Today, Design Therapeutics, Inc. stock is down by 3.28%, possibly due to recent market activity.

What is the market sentiment around Design Therapeutics, Inc. stock?

Current sentiment around Design Therapeutics, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Design Therapeutics, Inc.'s stock price growing?

Over the past month, Design Therapeutics, Inc.'s stock price has decreased by 25.89%.

How can I buy Design Therapeutics, Inc. stock?

You can buy Design Therapeutics, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol DSGN.

Who are the major shareholders of Design Therapeutics, Inc. stock?

Major shareholders of Design Therapeutics, Inc. include institutions such as SR One Capital Management LP, Point72 Capital Holdings LP, Logos Global Management LP, according to the latest filings.

DSGN

Design Therapeutics, Inc.

$10.78

3.28%

Trade Ideas Performance

Latest Closed Trade Idea

$10.78

3.28%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Design Therapeutics, Inc. (DSGN)

Over the past six months, Design Therapeutics' stock experienced several notable events. In November 2025, the company announced progress across its GeneTAC® candidates and reported a net loss of $17.0 million. December 2025 saw analysts increasing price targets and upgrades from Leerink Partners and RBC Capital. In January 2026, the price target was further increased, and Oppenheimer initiated coverage with an "Outperform" recommendation. March 2026 brought the report of fourth quarter and full year 2025 financial results, along with Jefferies Financial Group initiating coverage with a "Buy" recommendation. April 2026 saw the announcement of first quarter 2026 financial results and updates on clinical trials, with Piper Sandler reaffirming an "overweight" rating. In May 2026, Oppenheimer increased its price objective, Wall Street Zen upgraded the stock to a "hold" rating, and the company reported a smaller-than-expected quarterly loss.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community